Cite

HARVARD Citation

    Morabito, F. et al. (2020). An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma. Expert opinion on pharmacotherapy. pp. 29-38. [Online]. 
  
Back to record